Recent studies have shown that genomic instability in cancer benefits cancer immunotherapy, as it determines the immunogenicity of tumor cells through mechanisms including activating the cytosolic innate immunity mediated mainly by the cGAS-STING pathway22. Here, STING1 is linked to neoplasm.